DE60309465D1 - Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen - Google Patents

Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen

Info

Publication number
DE60309465D1
DE60309465D1 DE60309465T DE60309465T DE60309465D1 DE 60309465 D1 DE60309465 D1 DE 60309465D1 DE 60309465 T DE60309465 T DE 60309465T DE 60309465 T DE60309465 T DE 60309465T DE 60309465 D1 DE60309465 D1 DE 60309465D1
Authority
DE
Germany
Prior art keywords
women
prevention
treatment
symptoms
atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60309465T
Other languages
English (en)
Other versions
DE60309465T2 (de
Inventor
Taru Blom
Paula Groenroos
Kaija Halonen
Pirkko Haerkoenen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hormos Medical Ltd
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Publication of DE60309465D1 publication Critical patent/DE60309465D1/de
Application granted granted Critical
Publication of DE60309465T2 publication Critical patent/DE60309465T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
DE60309465T 2002-06-06 2003-05-14 Verfahren zur Hemmung oder Vorbeugung von urogenitaler Atrophie und deren Symptome bei Frauen Expired - Lifetime DE60309465T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38590402P 2002-06-06 2002-06-06
US385904P 2002-06-06
PCT/FI2003/000369 WO2003103649A1 (en) 2002-06-06 2003-05-14 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Publications (2)

Publication Number Publication Date
DE60309465D1 true DE60309465D1 (de) 2006-12-14
DE60309465T2 DE60309465T2 (de) 2007-08-30

Family

ID=29736123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309465T Expired - Lifetime DE60309465T2 (de) 2002-06-06 2003-05-14 Verfahren zur Hemmung oder Vorbeugung von urogenitaler Atrophie und deren Symptome bei Frauen

Country Status (24)

Country Link
EP (1) EP1509215B1 (de)
JP (1) JP4362442B2 (de)
KR (1) KR100991157B1 (de)
CN (2) CN101406464A (de)
AT (1) ATE344025T1 (de)
AU (1) AU2003227790B2 (de)
BR (1) BR0311613A (de)
CA (1) CA2484542C (de)
CY (1) CY1105787T1 (de)
DE (1) DE60309465T2 (de)
DK (1) DK1509215T3 (de)
ES (1) ES2270025T3 (de)
HR (1) HRP20041150B1 (de)
IL (1) IL164528A (de)
MX (1) MXPA04012220A (de)
NO (3) NO334090B1 (de)
NZ (1) NZ536118A (de)
PL (1) PL214242B1 (de)
PT (1) PT1509215E (de)
RU (1) RU2317816C2 (de)
SI (1) SI1509215T1 (de)
UA (1) UA79797C2 (de)
WO (1) WO2003103649A1 (de)
ZA (1) ZA200408321B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
SI1742618T1 (sl) 2004-05-04 2012-12-31 Hormos Medical Ltd. Tekoäśe oralne formulacije ospemifena
CA2654152A1 (en) 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
EP2821385B1 (de) 2007-02-14 2016-07-27 Hormos Medical Ltd. Verfahren zur Herstellung von therapeutisch nützlichen Triphenylbutenderivaten
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
EP2909164A1 (de) 2012-10-19 2015-08-26 Fermion Oy Verfahren zur herstellung von ospemifen
KR102052133B1 (ko) 2017-08-10 2019-12-05 고려대학교 산학협력단 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352699A (en) * 1992-04-30 1994-10-04 University Of Massachusetts Medical Center Use of retinioc acid to treat vaginal atrophy
US5461064A (en) * 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
US5747059A (en) * 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
IL149990A0 (en) * 2000-01-28 2002-12-01 Endorech Inc Selective estrogen receptor modulators in combination with estrogens
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
HRP20041150A2 (en) 2006-03-31
UA79797C2 (en) 2007-07-25
ES2270025T3 (es) 2007-04-01
RU2317816C2 (ru) 2008-02-27
EP1509215B1 (de) 2006-11-02
NO336612B1 (no) 2015-10-12
HRP20041150B1 (en) 2007-06-30
NO20150487L (no) 2004-12-22
MXPA04012220A (es) 2005-04-08
KR100991157B1 (ko) 2010-11-02
ATE344025T1 (de) 2006-11-15
IL164528A (en) 2010-06-30
CA2484542A1 (en) 2003-12-18
CY1105787T1 (el) 2011-02-02
DK1509215T3 (da) 2007-03-12
PL372758A1 (en) 2005-08-08
EP1509215A1 (de) 2005-03-02
NZ536118A (en) 2007-08-31
WO2003103649A1 (en) 2003-12-18
JP2005532353A (ja) 2005-10-27
CN100448437C (zh) 2009-01-07
PL214242B1 (pl) 2013-07-31
SI1509215T1 (sl) 2007-02-28
DE60309465T2 (de) 2007-08-30
NO334090B1 (no) 2013-12-09
ZA200408321B (en) 2006-07-26
CN1658851A (zh) 2005-08-24
NO339194B1 (no) 2016-11-14
JP4362442B2 (ja) 2009-11-11
CN101406464A (zh) 2009-04-15
NO20044568L (no) 2004-12-22
PT1509215E (pt) 2007-01-31
RU2004138571A (ru) 2005-06-10
AU2003227790A1 (en) 2003-12-22
KR20050004292A (ko) 2005-01-12
CA2484542C (en) 2010-11-02
NO20131189L (no) 2004-12-22
IL164528A0 (en) 2005-12-18
BR0311613A (pt) 2005-03-08
AU2003227790B2 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
EE200300031A (et) Klimakteersete häirete ravimeetod naistel menopausi ajal või järel
TW200501976A (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
ATE539751T1 (de) Verwendung von brimonidine zur behandlung von stress assoziierten zuständen
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
IL172419A0 (en) Piperazine derivatives and methods of use
TW200420549A (en) Thiazole derivatives
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
IS7315A (is) Útskipt díketópíperasín sem oxýtósínmótlyf
DE60309465D1 (de) Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen
SE0301883D0 (sv) New use II
SE0301884D0 (sv) New use III
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
ECSP055700A (es) Uso de derivados de 4-piridil-metil-ftalazina para la fabricación de un medicamento para el tratamiento de síndromes mielodisplásticos
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
ECSP993168A (es) Composicion y metodo para tratar enfermedades alergicas
ECSP993167A (es) Composicion y metodo para tratar enfermedades alergicas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition